Trademark applications and grants for Fuso Pharmaceutical Industries L T D. Fuso Pharmaceutical Industries L T D has 8 trademark applications. The latest application filed is for "HYBRISEP"
Patent Application | Date |
---|---|
ANTI-PD-L1 ANTIBODY 20220227871 - 17/579517 Konnai; Satoru ;   et al. | 2022-07-21 |
RESERVOIR ASSEMBLY FOR PROVIDING CARDIOPLEGIC SOLUTION CONTAINING BICARBONATE ION, AND METHOD FOR MANUFACTURING THE SAME 20220203009 - 17/600274 TOKUOKA; Shogo ;   et al. | 2022-06-30 |
NOVEL COMPOUND HAVING PD-L1 EXPRESSION-SUPPRESSING ACTION 20220194900 - 17/602331 KIKUCHI; Haruhisa ;   et al. | 2022-06-23 |
PHARMACEUTICAL COMPOSITION FOR INTRAOCULAR OR ORAL ADMINISTRATION FOR TREATMENT OF RETINAL DISEASES 20220096410 - 17/422057 YAMADA; Ken-ichi ;   et al. | 2022-03-31 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMENTIA AND CEREBROVASCULAR DISORDERS 20220023283 - 17/421921 YAMADA; Ken-ichi ;   et al. | 2022-01-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.